NCM
LLY icon

Noesis Capital Mangement’s Eli Lilly LLY Stock Holding History

Noesis Capital Mangement’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Sell
268
-29
-10% -$29.6K 0.04% 100
2026
Q1 		$273K Sell
297
-7
-2% -$7.1K 0.04% 104
2025
Q4 		$327K Buy
304
+9
+3% +$8.61K 0.05% 92
2025
Q3 		$225K Sell
295
-5
-2% -$3.72K 0.03% 116
2025
Q2 		$234K Sell
300
-109
-27% -$84.7K 0.04% 116
2025
Q1 		$338K Buy
409
+101
+33% +$84K 0.07% 88
2024
Q4 		$238K Buy
308
+11
+4% +$9.11K 0.05% 101
2024
Q3 		$263K Sell
297
-10
-3% -$8.99K 0.05% 101
2024
Q2 		$278K Sell
307
-9
-3% -$7.2K 0.06% 88
2024
Q1 		$246K Sell
316
-623
-66% -$443K 0.05% 82
2023
Q4 		$547K Sell
939
-10
-1% -$5.84K 0.13% 65
2023
Q3 		$510K Sell
949
-45
-5% -$23.2K 0.13% 65
2023
Q2 		$466K Sell
994
-60
-6% -$25.2K 0.11% 68
2023
Q1 		$362K Sell
1,054
-30
-3% -$10.1K 0.09% 72
2022
Q4 		$397K Hold
1,084
– – 0.11% 66
2022
Q3 		$351K Sell
1,084
-133
-11% -$42.1K 0.11% 66
2022
Q2 		$395K Sell
1,217
-30
-2% -$9.01K 0.12% 67
2022
Q1 		$357K Sell
1,247
-1,662
-57% -$428K 0.09% 75
2021
Q4 		$804K Buy
2,909
+300
+11% +$76.1K 0.16% 56
2021
Q3 		$603K Buy
2,609
+1,250
+92% +$309K 0.12% 63
2021
Q2 		$316K Sell
1,359
-59
-4% -$11.9K 0.06% 87
2021
Q1 		$265K Sell
1,418
-42
-3% -$8.22K 0.06% 98
2020
Q4 		$247K Hold
1,460
– – 0.06% 98
2020
Q3 		$216K Hold
1,460
– – 0.06% 99
2020
Q2 		$240K Hold
1,460
– – 0.08% 90
2020
Q1 		$203K Sell
1,460
-200
-12% -$27.5K 0.07% 99
2019
Q4 		$218K Buy
+1,660
New +$192K 0.06% 116

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Noesis Capital Mangement's LLY Position: Q2 2026 in Review

Noesis Capital Mangement reduced its Eli Lilly (LLY) stake by 9.8% in Q2 2026, selling an estimated $29.6K and leaving 268 shares worth $322K. The position accounts for 0.04% of the portfolio, ranked #100.

Noesis Capital Mangement first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. The position peaked at $804K in Q4 2021. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Noesis Capital Mangement held 268 shares of Eli Lilly worth $322K as of Q2 2026.
  • Noesis Capital Mangement sold 29 Eli Lilly shares in Q2 2026, an estimated $29.6K.
  • Eli Lilly made up 0.04% of Noesis Capital Mangement's portfolio in Q2 2026, its #100 holding.
  • Noesis Capital Mangement first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • Noesis Capital Mangement's Eli Lilly position peaked at $804K in Q4 2021.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Noesis Capital Mangement's 13F filing for Q2 2026, filed 4 Aug 2026.